Skip to main content
Figure 1 | Journal of Translational Medicine

Figure 1

From: Pre-immature dendritic cells (PIDC) pulsed with HPV16 E6 or E7 peptide are capable of eliciting specific immune response in patients with advanced cervical cancer

Figure 1

FACS analysis showing the phenotype of PIDCs used in the vaccine preparation. A) After a two day incubation in the presence of GM-CSF, and pulsating with HPV E7 peptide for two hours, CD14 positive cells persistently expressed CD14 at a slightly lower level. B) CD14 positive cells expressed a higher level of CD80 following incubation with GM-CSF and HPV E7 peptide. C) CD14 positive cells expressed a higher level of CD86 following incubation with GM-CSF and HPV E7 peptide. D) CD14 positive cells expressed a higher level of CD1a following incubation with GM-CSF and HPV E7 peptide. E) CD14 positive cells expressed a higher level of the Mannose receptor (CD206) following incubation with GM-CSF and HPV E7 peptide. F) HLA-DR was up-regulated in CD14 positive cells following incubation with GM-CSF and HPV E7 peptide.

Back to article page